| Home > Quotes & Charts > News |
|
Abattis Bioceuticals Corp. (FLU:CNX) Exchange: Canadian National Stock Exchange
|
$0.095 
May 20, 2013, 11:02 AM EDT
Change:
-0.01 (-5.00%)
Volume: 30,000
Day Low
0.095
0.095
Day High
0.095
0.095
News Headlines for Abattis Bioceuticals Corp.
Tuesday, March 12, 2013
3:39 PM EDTAbattis Provides $10,000 Sponsorship to the American Herbal Pharmacopoeia for Cannabis Monograph Project - Canada Newswire
3:38 PM EDTAbattis Provides $10,000 Sponsorship to the American Herbal Pharmacopoeia for Cannabis Monograph Project - PR Newswire
Monday, March 11, 2013
2:31 PM EDTAbattis Terminates $600,000 Private Placement - Canada Newswire
Friday, March 8, 2013
3:54 PM ESTAbattis Participates In Project On A Whole Plant Therapeutic For Treating Malaria And Other Diseases And Reducing Drug Resistance - Canada Newswire
3:53 PM ESTAbattis Participates In Project On A Whole Plant Therapeutic For Treating Malaria And Other Diseases And Reducing Drug Resistance - PR Newswire
Wednesday, March 6, 2013
7:23 AM ESTAbattis Signs LOI With Crudessence Kombucha Inc. To License Infused, Blended Kombucha Tea - PR Newswire
Tuesday, March 5, 2013
5:00 AM ESTAbattis Signs LOI to be North American Distributor of Cromogen's Cannabinoid Class Compound "Cannabidiol" or "CBD" - PR Newswire
5:00 AM ESTAbattis Signs LOI to be North American Distributor of Cromogen's Cannabinoid Class Compound "Cannabidiol" or "CBD" - Canada Newswire
Monday, March 4, 2013
7:47 AM ESTDr. Paula Brown appointed to board of wholly owned subsidiary Biocell Labs Inc. and acquires formulations - Canada Newswire
7:47 AM ESTDr. Paula Brown appointed to board of wholly owned subsidiary Biocell Labs Inc. and acquires formulations - PR Newswire
Thursday, February 21, 2013
3:47 PM ESTAbattis engages Triangle Consultants to advise on federal regulatory affairs - Canada Newswire
Monday, February 4, 2013
5:00 AM ESTAbattis engages British Columbia Institute of Technology to study growth rates and compounds in spinach - PR Newswire
5:00 AM ESTAbattis engages British Columbia Institute of Technology to study growth rates and compounds in spinach - Canada Newswire
Thursday, January 24, 2013
12:27 PM ESTMike Withrow, Abattis Bioceuticals Corp. CEO, is Interviewed on CEONews.Tv - PR Newswire
Wednesday, January 16, 2013
5:00 AM ESTAbattis receives US and Taiwan trademark approvals for anti-viral brand Defenzall(tm) - Canada Newswire
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. View delay times for all exchanges.
Market Data powered by QuoteMedia. See the QuoteMedia and TMX Group Terms of Use.
Market Data powered by QuoteMedia. See the QuoteMedia and TMX Group Terms of Use.
